Quantcast

Latest Ischemia Stories

2011-02-10 12:14:39

Study from Cedars-Sinai Medical Center presented at American Heart Association International Stroke Conference Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices. The scientists created a new molecule from curcumin, a chemical component of the golden-colored spice turmeric, and found in laboratory experiments that it affects mechanisms that protect and help...

2011-02-10 07:00:00

PORTOLA VALLEY, Calif., Feb. 10, 2011 /PRNewswire/ -- Spectros Corporation announces that sales and licensing revenue rose 32% (year-over-year) in 2010. This is the third year in a row for double-digit revenue growth for Spectros since the current T-Stat product line was launched in 2008. Spectros released certain 2010 financial results to shareholders today. "This is a sign of the significant and growing reliance of physicians, patients, and hospitals on state-of-the-art tissue...

2011-02-09 06:00:00

MOUNTAIN VIEW, Calif., Feb. 9, 2011 /PRNewswire/ -- Concentric Medical, Inc. today announced that the first patients were enrolled in TREVO 2 (Thrombectomy REvascularization of large Vessel Occlusions) at Oregon Health & Science University in Portland, Oregon and at Capital Health in Trenton, New Jersey. Oregon Health & Science enrolled the first patient in TREVO 2 and Capital Health was first to use the Trevo device. TREVO 2 is a pivotal clinical trial investigating the safety and...

2011-01-26 06:00:00

MOUNTAIN VIEW, Calif., Jan. 26, 2011 /PRNewswire/ -- Marking a major milestone toward expanding the use of Stentriever(TM) technology for stroke patients, Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo(TM) System in Canada. The Trevo System is an innovative, high-performing, easy-to-use system that utilizes Stentriever technology for the removal of clots that cause stroke. The...

2011-01-17 22:13:02

Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart attack). The findings were published online in Cardiovascular Revascularization Medicine and will be presented at The Sixth International Conference on Cell Therapy for Cardiovascular Disease at Columbia University Medical Center, New York City, on January 20, 2011....

2011-01-12 16:31:17

A new study identifies a molecule that is a critical regulator of neuron survival after ischemic brain injury. The research, published by Cell Press in the January 13 issue of the journal Neuron, may lead to new therapies that reduce damage after a stroke or other injuries that involve an interruption in blood supply to the brain. Ischemic brain injury is damage caused by a restriction in blood supply. Neuronal death after an interruption in the supply of oxygen and glucose involves a complex...

2011-01-03 07:00:00

CLEVELAND, Jan. 3, 2011 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI). JVS-100 encodes Stromal-cell Derived Factor 1 (SDF-1), which has been shown in several pre-clinical...

2010-12-08 05:55:00

MERION STATION, Pa., Dec. 8, 2010 /PRNewswire-USNewswire/ -- After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it? While researching cardiac arrest, Jeffrey Dobkin read about a boy drowning in icy waters. Although submerged for over half an hour the boy was rescued, resuscitated, and recovered completely. No brain damage. Dobkin wondered: How can someone drown and experience no brain damage?...

2010-12-06 08:00:00

SAN DIEGO, Dec. 6, 2010 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that it has entered into a Cooperative Research And Development Agreement (CRADA) with the U.S. Navy to evaluate its investigational biopharmaceutical product MP4 as a treatment for traumatic...

2010-11-22 06:01:00

BAAR, Switzerland and TEL AVIV, November 22, 2010 /PRNewswire-FirstCall/ -- SCHILLER AG, a leading international manufacturer and supplier of cardiopulmonary diagnostics and BSP Biological Signal Processing Ltd., a medical device company that develops and markets innovative solutions for noninvasive cardiac diagnosis and monitoring , announced on November 8th, 2010 the signing of an agreement to jointly develop a new product line based on BSP's HyperQ(TM) technology. The project will be...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related